Guarini A - Search Results

1

mTOR as a target of everolimus in refractory/relapsed Hodgkin lymphoma.

Guarini A, Minoia C, Giannoccaro M, Rana A, Iacobazzi A, Lapietra A, Raimondi A, Silvestris N, Gadaleta CD, Ranieri G. Guarini A, et al. Curr Med Chem. 2012;19(7):945-54. doi: 10.2174/092986712799320727. Curr Med Chem. 2012. PMID: 22214465 Review.

2

Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.

Liso V, Capalbo S, Lapietra A, Pavone V, Guarini A, Specchia G. Liso V, et al. Among authors: guarini a. Haematologica. 1999 Mar;84(3):212-7. Haematologica. 1999. PMID: 10189384

3

Primary non Hodgkin's lymphoma of the vagina.

Guarini A, Pavone V, Valentino T, Rana A, Di Vagno G, Maiorano E, Liso V. Guarini A, et al. Leuk Lymphoma. 1999 Nov;35(5-6):619-22. doi: 10.1080/10428199909169628. Leuk Lymphoma. 1999. PMID: 10609801 Review.

4

"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese".

Mele G, Melpignano A, Quarta G, Palumbo G, Capalbo S, Falcone A, Cascavilla N, Palazzo G, Mazza P, Iannitto E, Curci P, Rizzi R, Specchia G, Rossini B, Pavone V, Ria R, Vacca A, Buquicchio C, Tarantini G, Minoia C, Guarini A, Ditonno P, Polimeno G, Reddiconto G, Di Renzo N. Mele G, et al. Among authors: guarini a. Leuk Res. 2015 Mar;39(3):279-83. doi: 10.1016/j.leukres.2014.12.007. Epub 2014 Dec 23. Leuk Res. 2015. PMID: 25636354

5

u-PAR expression in cancer associated fibroblast: new acquisitions in multiple myeloma progression.

Ciavarella S, Laurenzana A, De Summa S, Pilato B, Chillà A, Lacalamita R, Minoia C, Margheri F, Iacobazzi A, Rana A, Merchionne F, Fibbi G, Del Rosso M, Guarini A, Tommasi S, Serratì S. Ciavarella S, et al. Among authors: guarini a. BMC Cancer. 2017 Mar 24;17(1):215. doi: 10.1186/s12885-017-3183-y. BMC Cancer. 2017. PMID: 28340565 Free PMC article.

6

Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma.

Porcelli L, Stolfa D, Stefanachi A, Di Fonte R, Garofoli M, Iacobazzi RM, Silvestris N, Guarini A, Cellamare S, Azzariti A. Porcelli L, et al. Among authors: guarini a. Cancer Lett. 2019 Mar 31;445:1-10. doi: 10.1016/j.canlet.2018.12.013. Epub 2018 Dec 22. Cancer Lett. 2019. PMID: 30583077

7

Body Composition Change, Unhealthy Lifestyles and Steroid Treatment as Predictor of Metabolic Risk in Non-Hodgkin's Lymphoma Survivors.

Daniele A, Guarini A, Summa S, Dellino M, Lerario G, Ciavarella S, Ditonno P, Paradiso AV, Divella R, Casamassima P, Savino E, Carbonara MD, Minoia C. Daniele A, et al. Among authors: guarini a. J Pers Med. 2021 Mar 17;11(3):215. doi: 10.3390/jpm11030215. J Pers Med. 2021. PMID: 33802940 Free PMC article.

8

Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma.

Pavone V, Gaudio F, Guarini A, Perrone T, Zonno A, Curci P, Liso V. Pavone V, et al. Among authors: guarini a. Bone Marrow Transplant. 2002 Feb;29(4):285-90. doi: 10.1038/sj.bmt.1703364. Bone Marrow Transplant. 2002. PMID: 11896424 Clinical Trial.

9

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.

Cortelezzi A, Sciumè M, Liberati AM, Vincenti D, Cuneo A, Reda G, Laurenti L, Zaja F, Marasca R, Chiarenza A, Gritti G, Orsucci L, Storti S, Angelucci E, Cascavilla N, Gobbi M, Mauro FR, Morabito F, Fabris S, Piciocchi A, Vignetti M, Neri A, Rossi D, Giannarelli D, Guarini A, Foà R. Cortelezzi A, et al. Among authors: guarini a. Leukemia. 2014 Mar;28(3):642-8. doi: 10.1038/leu.2013.334. Epub 2013 Nov 13. Leukemia. 2014. PMID: 24220274 Clinical Trial.

10

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.

Mauro FR, Carella AM, Molica S, Paoloni F, Liberati AM, Zaja F, Belsito V, Cortellezzi A, Rizzi R, Tosi P, Spriano M, Ferretti A, Nanni M, Marinelli M, De Propris MS, Orlando SM, Vignetti M, Cuneo A, Guarini AR, Foà R. Mauro FR, et al. Among authors: guarini ar. Leuk Lymphoma. 2017 Jul;58(7):1640-1647. doi: 10.1080/10428194.2016.1258698. Epub 2016 Nov 23. Leuk Lymphoma. 2017. PMID: 27881039 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page